Trends and developments in liposome drug delivery systems
- PMID: 11357170
- DOI: 10.1002/jps.1023
Trends and developments in liposome drug delivery systems
Abstract
Since the discovery of liposomes or lipid vesicles derived from self-forming enclosed lipid bilayers upon hydration, liposome drug delivery systems have played a significant role in formulation of potent drugs to improve therapeutics. Currently, most of these liposome formulations are designed to reduce toxicity and to some extent increase accumulation at the target site(s) in a number of clinical applications. The current pharmaceutical preparations of liposome-based therapeutics stem from our understanding of lipid-drug interactions and liposome disposition mechanisms including the inhibition of rapid clearance of liposomes by controlling size, charge, and surface hydration. The insight gained from clinical use of liposome drug delivery systems can now be integrated to design liposomes targeted to tissues and cells with or without expression of target recognition molecules on liposome membranes. Enhanced safety and heightened efficacy have been achieved for a wide range of drug classes, including antitumor agents, antivirals, antifungals, antimicrobials, vaccines, and gene therapeutics. Additional refinements of biomembrane sensors and liposome delivery systems that are effective in the presence of other membrane-bound proteins in vivo may permit selective delivery of therapeutic compounds to selected intracellular target areas.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Liposomal drug delivery systems: an update review.Curr Drug Deliv. 2007 Oct;4(4):297-305. doi: 10.2174/156720107782151269. Curr Drug Deliv. 2007. PMID: 17979650 Review.
-
Liposomal drug delivery systems--clinical applications.Acta Pharm. 2005 Mar;55(1):1-25. Acta Pharm. 2005. PMID: 15907221 Review.
-
Designing of 'intelligent' liposomes for efficient delivery of drugs.J Cell Mol Med. 2002 Oct-Dec;6(4):465-74. doi: 10.1111/j.1582-4934.2002.tb00450.x. J Cell Mol Med. 2002. PMID: 12611636 Free PMC article. Review.
-
Liposome-based delivery system for vaccine candidates: constructing an effective formulation.Nanomedicine (Lond). 2012 Dec;7(12):1877-93. doi: 10.2217/nnm.12.157. Nanomedicine (Lond). 2012. PMID: 23249332 Review.
-
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.J Pharm Sci. 2014 Jan;103(1):29-52. doi: 10.1002/jps.23773. Epub 2013 Nov 25. J Pharm Sci. 2014. PMID: 24338748 Free PMC article. Review.
Cited by
-
Drug delivery using platelet cancer cell interaction.Pharm Res. 2013 Nov;30(11):2785-94. doi: 10.1007/s11095-013-1097-1. Epub 2013 Jun 6. Pharm Res. 2013. PMID: 23739991
-
NIR-activated content release from plasmon resonant liposomes for probing single-cell responses.ACS Nano. 2012 Nov 27;6(11):9383-91. doi: 10.1021/nn304434a. Epub 2012 Nov 7. ACS Nano. 2012. PMID: 23106797 Free PMC article.
-
Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.J Zhejiang Univ Sci B. 2012 Dec;13(12):981-9. doi: 10.1631/jzus.B1200098. J Zhejiang Univ Sci B. 2012. PMID: 23225853 Free PMC article.
-
Magnetoliposomes loaded with poly-unsaturated fatty acids as novel theranostic anti-inflammatory formulations.Theranostics. 2015 Feb 15;5(5):489-503. doi: 10.7150/thno.10069. eCollection 2015. Theranostics. 2015. PMID: 25767616 Free PMC article.
-
Effect of Vitamin E and a Long-Chain Alcohol n-Octanol on the Carbohydrate-Based Nonionic Amphiphile Sucrose Monolaurate-Formulation of Newly Developed Niosomes and Application in Cell Imaging.ACS Omega. 2017 Nov 30;2(11):7637-7646. doi: 10.1021/acsomega.7b00744. Epub 2017 Nov 7. ACS Omega. 2017. PMID: 30023559 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical